Total Payments
$2,985
2024 Payments
$490.99
Companies
27
Transactions
159
Medicare Patients
6,416
Medicare Billing
$320,375
Payment Breakdown by Category
Food & Beverage$2,985 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,985 | 159 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $987.25 | 50 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $392.01 | 23 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $323.63 | 13 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $206.90 | 14 | $0 (2024) |
| PFIZER INC. | $201.16 | 11 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $141.90 | 8 | $0 (2024) |
| Merck Sharp & Dohme LLC | $117.45 | 7 | $0 (2023) |
| Edwards Lifesciences Corporation | $85.51 | 3 | $0 (2024) |
| Amgen Inc. | $67.80 | 4 | $0 (2023) |
| Amarin Pharma Inc. | $52.53 | 3 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $490.99 | 25 | Boston Scientific Corporation ($121.89) |
| 2023 | $284.56 | 15 | SANOFI-AVENTIS U.S. LLC ($56.08) |
| 2022 | $344.43 | 18 | Boston Scientific Corporation ($174.62) |
| 2021 | $395.93 | 22 | BOSTON SCIENTIFIC CORPORATION ($72.09) |
| 2020 | $183.64 | 9 | Boston Scientific Corporation ($65.40) |
| 2019 | $266.11 | 16 | Novartis Pharmaceuticals Corporation ($168.45) |
| 2018 | $379.85 | 26 | BOSTON SCIENTIFIC CORPORATION ($207.45) |
| 2017 | $639.69 | 28 | BOSTON SCIENTIFIC CORPORATION ($285.45) |
All Payment Transactions
159 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.37 | General |
| Category: Cardiovascular | ||||||
| 11/19/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/15/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.51 | General |
| Category: Cardiovascular | ||||||
| 11/07/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $21.58 | General |
| Category: Cardiovascular | ||||||
| 11/06/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $31.11 | General |
| 11/04/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/16/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/04/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $14.91 | General |
| Category: Cardiovascular | ||||||
| 10/02/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: DIABETES | ||||||
| 09/11/2024 | Boston Scientific Corporation | ACCOLADE SR (Device) | Food and Beverage | In-kind items and services | $30.23 | General |
| Category: ACCOLADE_CRM | ||||||
| 09/11/2024 | Edwards Lifesciences Corporation | EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) | Food and Beverage | In-kind items and services | $26.35 | General |
| Category: Transcatheter Heart Valves | ||||||
| 08/20/2024 | iRhythm Technologies, Inc. | Zio monitor (Device), ZIO XT Patch | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/19/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/24/2024 | Boston Scientific Corporation | LUX-Dx Insertable Cardiac Monitor (Device) | Food and Beverage | In-kind items and services | $25.78 | General |
| Category: LUX-Dx_CRM | ||||||
| 05/16/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/13/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/17/2024 | Boston Scientific Corporation | LUX-Dx Insertable Cardiac Monitor (Device) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: LUX-Dx_CRM | ||||||
| 03/12/2024 | Edwards Lifesciences Corporation | EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) | Food and Beverage | In-kind items and services | $44.03 | General |
| Category: Transcatheter Heart Valves | ||||||
| 02/23/2024 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/16/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.78 | General |
| Category: Cardiovascular | ||||||
| 01/26/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/19/2024 | Boston Scientific Corporation | LUX-Dx Insertable Cardiac Monitor (Device) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: LUX-Dx_CRM | ||||||
| 01/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/04/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,779 | 2,191 | $365,941 | $89,966 |
| 2022 | 18 | 1,729 | 1,982 | $316,955 | $75,114 |
| 2021 | 16 | 1,406 | 1,738 | $317,381 | $79,603 |
| 2020 | 19 | 1,502 | 1,839 | $314,144 | $75,692 |
Total Patients
6,416
Total Services
7,750
Medicare Billing
$320,375
Procedure Codes
69
All Medicare Procedures & Services
69 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 257 | 349 | $109,586 | $29,625 | 27.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 199 | 202 | $42,016 | $9,596 | 22.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 60 | 100 | $30,900 | $9,139 | 29.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 56 | 69 | $29,325 | $8,229 | 28.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 60 | 63 | $37,926 | $8,130 | 21.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 64 | 89 | $18,779 | $5,318 | 28.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 302 | 443 | $31,896 | $4,358 | 13.7% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 63 | 63 | $14,868 | $3,618 | 24.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 477 | 570 | $14,820 | $3,278 | 22.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 26 | 26 | $12,532 | $2,991 | 23.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 16 | 16 | $6,512 | $1,598 | 24.5% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 73 | 74 | $4,810 | $1,179 | 24.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 19 | 19 | $4,009 | $936.19 | 23.4% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 11 | 11 | $3,531 | $895.07 | 25.3% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 76 | 77 | $3,311 | $822.36 | 24.8% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Facility | 2023 | 20 | 20 | $1,120 | $253.26 | 22.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 202 | 254 | $79,756 | $21,138 | 26.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 252 | 260 | $58,724 | $13,168 | 22.4% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2022 | 87 | 87 | $20,532 | $5,256 | 25.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 33 | 34 | $20,468 | $5,119 | 25.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 54 | 80 | $16,880 | $4,293 | 25.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 33 | 35 | $14,875 | $3,946 | 26.5% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2022 | 21 | 21 | $18,354 | $3,817 | 20.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 35 | 49 | $15,141 | $3,735 | 24.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 469 | 542 | $14,092 | $3,155 | 22.4% |
About Dr. John Girod, DO
Dr. John Girod, DO is a Cardiovascular Disease healthcare provider based in Bethel Park, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/23/2007. The National Provider Identifier (NPI) number assigned to this provider is 1902016405.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Girod, DO has received a total of $2,985 in payments from pharmaceutical and medical device companies, with $490.99 received in 2024. These payments were reported across 159 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($2,985).
As a Medicare-enrolled provider, Girod has provided services to 6,416 Medicare beneficiaries, totaling 7,750 services with total Medicare billing of $320,375. Data is available for 4 years (2020–2023), covering 69 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Bethel Park, PA
- Active Since 05/23/2007
- Last Updated 03/15/2021
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1902016405
Products in Payments
- ENTRESTO (Drug) $326.79
- XARELTO (Drug) $323.63
- ELIQUIS (Drug) $301.43
- COMET (Device) $247.49
- MULTAQ (Drug) $141.90
- VERQUVO (Drug) $117.45
- LUX-Dx Insertable Cardiac Monitor (Device) $99.64
- EMBLEM (Device) $85.99
- EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) $70.38
- LEQVIO (Drug) $65.22
- EMBLEM MRI S-ICD (Device) $58.90
- CAMZYOS (Drug) $53.35
- VYNDAQEL (Drug) $53.28
- Vascepa (Drug) $52.53
- GENERAL - STENTS (Device) $50.86
- Repatha (Biological) $50.63
- SYNERGY BIOABSORBABLE POLYMER DRUG-ELUTING STENT SYSTEM (Device) $41.87
- CorPath GRX (Device) $34.75
- CorPath Imaging System (Device) $32.01
- LifeVest (Device) $31.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Bethel Park
Dr. Christopher Pray, M.d, M.D
Cardiovascular Disease — Payments: $210,294
Cardiovascular Disease $210,294
Robert Shogry, Md, MD
Cardiovascular Disease — Payments: $30,750
Cardiovascular Disease $30,750
James Macdougall, Md, MD
Cardiovascular Disease — Payments: $1,057
Cardiovascular Disease $1,057
Jennifer Berliner
Cardiovascular Disease
Cardiovascular Disease